ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30
Advanced Biomed Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$4.16+0.18 (+4.52%)
Close on Oct 19, 2026
- Market cap
- $6.51M
- P/E (TTM)
- 0.8
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Advanced Biomed has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Advanced Biomed filed with the SEC
PRESS RELEASE ISSUED BY ADVANCED BIOMED INC., DATED FEBRUARY 18, 2026
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED DECEMBER 30, 2025
Material agreement · Acquisition or disposition completed · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, DATED SEPTEMBER 19, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
Advanced Biomed Inc. Announces Pricing of Initial Public Offering
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K